M
Molecure SA
WSE:MOC
Molecure SA
WSE:MOC
Price:
9.2
PLN
2.22%
Market Closed
Market Cap:
185.8m
PLN
Balance Sheet
Balance Sheet Decomposition
Molecure SA
Molecure SA
| Current Assets | 54.5m |
| Cash & Short-Term Investments | 52.4m |
| Receivables | 637.4k |
| Other Current Assets | 1.5m |
| Non-Current Assets | 54.3m |
| PP&E | 9.9m |
| Intangibles | 44.4m |
Balance Sheet
Molecure SA
Molecure SA
Currency: PLN
Millions
Annual
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
3
|
13
|
52
|
34
|
121
|
102
|
66
|
64
|
|
| Cash |
3
|
6
|
5
|
3
|
121
|
102
|
13
|
10
|
|
| Cash Equivalents |
0
|
8
|
47
|
31
|
0
|
0
|
53
|
54
|
|
| Total Receivables |
0
|
1
|
1
|
1
|
9
|
13
|
8
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Current Assets |
3
|
14
|
53
|
35
|
130
|
116
|
75
|
66
|
|
| PP&E Net |
3
|
3
|
3
|
6
|
8
|
10
|
12
|
11
|
|
| PP&E Gross |
3
|
3
|
3
|
6
|
8
|
10
|
12
|
11
|
|
| Accumulated Depreciation |
2
|
3
|
5
|
6
|
7
|
8
|
10
|
12
|
|
| Intangible Assets |
10
|
18
|
31
|
45
|
16
|
26
|
51
|
36
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
16
N/A
|
35
+123%
|
86
+149%
|
86
0%
|
153
+79%
|
152
-1%
|
138
-9%
|
112
-19%
|
|
| Liabilities | |||||||||
| Accounts Payable |
1
|
2
|
3
|
2
|
1
|
2
|
3
|
3
|
|
| Accrued Liabilities |
0
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
1
|
2
|
2
|
2
|
2
|
|
| Other Current Liabilities |
1
|
2
|
0
|
0
|
3
|
2
|
1
|
0
|
|
| Total Current Liabilities |
2
|
5
|
4
|
4
|
7
|
6
|
7
|
6
|
|
| Long-Term Debt |
0
|
0
|
0
|
3
|
3
|
4
|
4
|
5
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
3
N/A
|
5
+93%
|
4
-15%
|
7
+59%
|
10
+54%
|
10
+3%
|
12
+11%
|
11
-2%
|
|
| Equity | |||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
3
|
6
|
10
|
14
|
50
|
40
|
25
|
50
|
|
| Additional Paid In Capital |
16
|
34
|
89
|
89
|
89
|
98
|
101
|
151
|
|
| Other Equity |
0
|
1
|
3
|
4
|
4
|
3
|
0
|
0
|
|
| Total Equity |
13
N/A
|
30
+129%
|
82
+176%
|
79
-3%
|
143
+81%
|
141
-2%
|
126
-10%
|
101
-20%
|
|
| Total Liabilities & Equity |
16
N/A
|
35
+123%
|
86
+149%
|
86
0%
|
153
+79%
|
152
-1%
|
138
-9%
|
112
-19%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
12
|
12
|
14
|
14
|
14
|
14
|
14
|
17
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
